APON(SZ:300753) Xin Lang Cai Jing·2025-08-26 07:41Group 1 - The core viewpoint of the news is that Aipeng Medical experienced a decline in stock price, dropping by 5.02% to 34.47 CNY per share, with a trading volume of 419 million CNY and a turnover rate of 13.59%, resulting in a total market capitalization of 4.345 billion CNY [1] - Aipeng Medical, established on October 30, 2001, and listed on December 13, 2018, specializes in the development, production, and sales of medical devices in the fields of pain management and nasal care [1] - The company's main business revenue composition includes pain management products at 61.52%, nasal and upper airway products at 30.55%, other products at 7.55%, and other businesses at 0.37% [1] Group 2 - According to data from the top ten heavy stocks of funds, Beixin Ruifeng Fund holds a significant position in Aipeng Medical, with its health living theme flexible allocation fund (001056) holding 120,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest heavy stock [2] - The fund, established on March 27, 2015, has a latest scale of 89.3779 million CNY, with a year-to-date return of 40.86%, ranking 1022 out of 8194 in its category, and a one-year return of 81.22%, ranking 687 out of 7962 [2] - The fund manager, Pang Wenjie, has been in position for 5 years and 88 days, with the fund's total asset scale at 17 million CNY, achieving a best return of 44.46% and a worst return of -44.25% during his tenure [3]